These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33872466)

  • 1. 3D human liver spheroids for translational pharmacology and toxicology.
    Ingelman-Sundberg M; Lauschke VM
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130 Suppl 1():5-15. PubMed ID: 33872466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions.
    Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
    Toxicol Sci; 2018 Jun; 163(2):655-665. PubMed ID: 29590495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
    Foster AJ; Chouhan B; Regan SL; Rollison H; Amberntsson S; Andersson LC; Srivastava A; Darnell M; Cairns J; Lazic SE; Jang KJ; Petropolis DB; Kodella K; Rubins JE; Williams D; Hamilton GA; Ewart L; Morgan P
    Arch Toxicol; 2019 Apr; 93(4):1021-1037. PubMed ID: 30915487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro.
    Kammerer S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
    Andersson TB
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):234-238. PubMed ID: 28470941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis.
    Pingitore P; Sasidharan K; Ekstrand M; Prill S; Lindén D; Romeo S
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
    Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
    Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat.
    Kyriakides M; Hardwick RN; Jin Z; Goedken MJ; Holmes E; Cherrington NJ; Coen M
    Toxicol Sci; 2014 Nov; 142(1):105-16. PubMed ID: 25145655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury.
    Schofield CA; Walker TM; Taylor MA; Patel M; Vlachou DF; Macina JM; Vidgeon-Hart MP; Williams A; McGill PJ; Newman CF; Sakatis MZ
    Chem Res Toxicol; 2021 Dec; 34(12):2485-2499. PubMed ID: 34797640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development.
    Walker PA; Ryder S; Lavado A; Dilworth C; Riley RJ
    Arch Toxicol; 2020 Aug; 94(8):2559-2585. PubMed ID: 32372214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver Injury.
    Watkins PB
    Clin Liver Dis; 2020 Feb; 24(1):49-60. PubMed ID: 31753250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
    Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
    Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy.
    Vernetti LA; Vogt A; Gough A; Taylor DL
    Clin Liver Dis; 2017 Feb; 21(1):197-214. PubMed ID: 27842772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
    Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
    Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
    Bell CC; Hendriks DF; Moro SM; Ellis E; Walsh J; Renblom A; Fredriksson Puigvert L; Dankers AC; Jacobs F; Snoeys J; Sison-Young RL; Jenkins RE; Nordling Å; Mkrtchian S; Park BK; Kitteringham NR; Goldring CE; Lauschke VM; Ingelman-Sundberg M
    Sci Rep; 2016 May; 6():25187. PubMed ID: 27143246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
    Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
    Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of potential hepatotoxicity induced by drugs.
    Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
    Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.